|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 9/1611 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61K 47/02 | (2013.01) |
| (11) | Number of the document | 3860606 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19779488.6 |
| Date of filing the European patent application | 2019-10-01 | |
| (97) | Date of publication of the European application | 2021-08-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/076625 |
| Date | 2019-10-01 |
| (87) | Number | WO 2020/070147 |
| Date | 2020-04-09 |
| (30) | Number | Date | Country code |
| 18198662 | 2018-10-04 | EP |
| (72) |
NOGUEIRAS NIETO, Luis , ES
ALVAREZ FERNANDEZ, Lisardo , ES
|
| (73) |
Synthon B.V. ,
Microweg 22, 6545 CM Nijmegen,
NL
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING LENVATINIB ESYLATE OR TOSYLATE |
| PHARMACEUTICAL COMPOSITION COMPRISING LENVATINIB ESYLATE OR TOSYLATE |